
Nautilus Biotechnology Inc
NAUT121.50MMarket Cap
LossP/E TTM
Nautilus Biotechnology Inc
NAUT Balance Sheet
You can check out the annual or quarterly balance sheets of Nautilus Biotechnology Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing NAUT stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Nautilus Biotechnology Inc Have?
In its most recent quarterly, Nautilus Biotechnology Inc had 13.17M in cash and cash equivalents.
How Much Are Nautilus Biotechnology Inc's Total Liabilities?
Nautilus Biotechnology Inc reported 34.14M in total liabilities as of the latest reported quarter, including 7.95M in current liabilities and 26.19M in non-current liabilities.
What Are Nautilus Biotechnology Inc's Total Assets?
As of the latest reported quarter, Nautilus Biotechnology Inc's total assets were 191.11M, consisting of 105.96M in current assets and 85.15M in non-current assets.
How Much Shareholders' Equity Does Nautilus Biotechnology Inc Have?
Nautilus Biotechnology Inc reported 156.97M in total shareholders' equity as of the latest reported quarter.